Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Teva
Dow
Express Scripts
Cerilliant
Fuji
Healthtrust
McKesson
Moodys

Generated: April 19, 2018

DrugPatentWatch Database Preview

SELENOMETHIONINE SE 75 Drug Profile

« Back to Dashboard

When do Selenomethionine Se 75 patents expire, and what generic alternatives are available?

Selenomethionine Se 75 is a drug marketed by Ge Healthcare, Mallinckrodt, and Pharmalucence. and is included in three NDAs.

The generic ingredient in SELENOMETHIONINE SE 75 is selenomethionine se-75. There is one drug master file entry for this compound. Additional details are available on the selenomethionine se-75 profile page.
Summary for SELENOMETHIONINE SE 75
Drug patent expirations by year for SELENOMETHIONINE SE 75

US Patents and Regulatory Information for SELENOMETHIONINE SE 75

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare SELENOMETHIONINE SE 75 selenomethionine se-75 INJECTABLE;INJECTION 017257-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mallinckrodt SELENOMETHIONINE SE 75 selenomethionine se-75 INJECTABLE;INJECTION 017098-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmalucence SELENOMETHIONINE SE 75 selenomethionine se-75 INJECTABLE;INJECTION 017322-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Fish and Richardson
Dow
US Department of Justice
Queensland Health
Daiichi Sankyo
McKinsey
Cipla
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.